Merlin Crossley/X
Aug 21, 2026, 21:29
Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
Merlin Crossley, Deputy Vice-Chancellor Academic Quality at UNSW, shared a post on LinkedIn:
“Precision Medicine: Progress in science often comes from increasing precision.
In medicine precision improves diagnosis and treatment.
In my field – Sickle Cell Anemia – we now have a molecular understanding of the problem and atomic level treatments are being explored.
This is my latest commentary in the journal Blood about targeting protein domains to boost fetal globin repression.
At UNSW we are committed to Precision and Computational Medicine and believe that connecting our strengths in computing, engineering, molecular biology, and health will help drive further progress!”
Stay updated with Hemostasis Today.
-
Oct 8, 2026, 11:45Wolfgang Miesbach: Milvexian After Acute Coronary Syndrome – What LIBREXIA ACS Found
-
Oct 8, 2026, 11:36John Erbey: Kidney Disfunction as a Cause of Anemia
-
Oct 8, 2026, 11:31Navneet Mishra: Sitosterolemia as an Under-Recognised Cause of Cytopenias
-
Oct 8, 2026, 11:06Houman Khosravani: Stroke and Thrombosis – Bridging Neurology and Hemostasis
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus